Pharmacy Technician Certification Exam Practice Question
The Food and Drug Administration (FDA) recommends limiting the use of simvastatin 80 mg because it is known to increase the risk of:
Correct Answer: D
Rationale: Simvastatin 80 mg is associated with an elevated risk of muscle damage, specifically rhabdomyolysis, a serious condition that can lead to kidney failure. This risk is particularly significant in patients with certain pre-existing conditions or those taking interacting medications.
Option A, severe allergic reactions, is not a common side effect of simvastatin. Option B, visual disturbances, while possible with some medications, is not a known major risk associated with simvastatin. Option C, severe anemia, is not directly linked to simvastatin use. Thus, the emphasis on muscle damage is crucial for patient safety.
Unlock All Questions
Subscribe to Premium for full access to all practice questions, detailed rationales, and performance tracking.
Subscribe Now